 |
|
|
| |
The impact of removing all hepatitis B virus (HBV) testing and treatment restrictions
|
| |
| |
EASL 2023 june 21-24 vienna
H. Razavi 1, E. Musabaev 2, S. Sadirova 1, 2
1 CDA Foundation, Lafayette, Colorado, United States 2 Research Institute of Virology, Tashkent, Uzbekistan
Comparison of matched cohorts of treated hepatitis B virus (HBV) mono-infected individuals with treated HIV/HBV co-infected individuals show a 60% reduction in HCC incidence as result of earlier treatment initiation in the HIV/HBV co-infected cohorts.1,2 Reducing HBV related mortality by 65% by 2030 is not possible without easing the current HBV treatment guidelines.
------------------------------
HIV Infection and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus (HBV) Co-infection: a Propensity Score-matched Cohort Study
HIV/HBV confected 1.2% HCC (n=7) vs HBV Monoinfected 3.2% (n=75).
The question raised by this study & other research is - Should HBV Treatment Begin Immediately ?? There seems to be good reasons clinically & scientifically to begin treatment as soon as possible ???? Jules
https://www.natap.org/2022/HBV/081622_01.htm
Risk of Hepatocellular Carcinoma among Persons Living with HIV and Viral Hepatitis Coinfection in the United States and Canada, 1996-2015
....https://www.natap.org/2020/CROI/croi_95.htm
------------------------------
|
| |
|
|
|
|
|
